Extracellular matrix type I collagen and associated cell-surface adhesion receptors plus locally retained platelet-derived growth factors from platelet-rich plasma (Type I Collagen-Integrin-PDGF-PRP Complex)

This target represents a multi-component therapeutic system used primarily in regenerative medicine and orthopedics. It consists of a type I collagen scaffold that mimics the natural extracellular matrix, providing the necessary mechanical environment and ligands for cell-surface adhesion receptors, specifically integrins. Within this matrix, platelet-derived growth factors (PDGF) sourced from platelet-rich plasma (PRP) are sequestered and slowly released to stimulate local cell populations. The synergy between the structural collagen, the adhesive signaling through integrins, and the mitogenic signaling from PDGF promotes accelerated wound healing, bone formation, and tendon repair. While highly effective in clinical settings for tissue augmentation, it is considered a composite entity rather than a single molecular target, involving complex interactions between structural proteins, signaling ligands, and their respective transmembrane receptors.

Other names

PRP-loaded collagen scaffoldCollagen-PDGF signaling complexPlatelet-rich plasma-enhanced collagen matrixType I collagen-integrin-growth factor axis

The complex acts as a bioactive scaffold where type I collagen provides structural support and binding sites for integrin receptors (e.g., alpha-2 beta-1), while locally retained PDGF from PRP binds to PDGF receptors (PDGFR-alpha/beta) to trigger intracellular signaling pathways like PI3K/Akt and MAPK, promoting cellular recruitment and tissue regeneration.